The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer

The integration of targeted agents to standard cytotoxic regimens has improved outcomes for patients with colorectal cancer (CRC) over recent years; however this malignancy remains the second leading cause of cancer mortality in industrialized countries. Small molecule inhibitors of heat shock prote...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Suqin, Smith, Donald L., Sequeira, Manuel, Sang, Jim, Bates, Richard C., Proia, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Preclinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101249/
https://www.ncbi.nlm.nih.gov/pubmed/24682747
http://dx.doi.org/10.1007/s10637-014-0095-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101249/
https://www.ncbi.nlm.nih.gov/pubmed/24682747
http://dx.doi.org/10.1007/s10637-014-0095-4

Ejemplares similares